Product Information
ACETAMINOPHEN ER 650 MG CAPLET is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.0631 per EA under NDC 70010016001. Its NADAC has been published 206 times since Oct 26, 2022.
FDA first approved this application on Apr 16, 2019.
Strength
650 mg/1
Manufacturer
Granules Pharmaceuticals Inc.NDC
70010016001
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHENApproval Type
Generic (ANDA)
FDA Application
ANDA211544FDA Approved
4/16/2019
On Market Since
2/15/2022
Price Statistics
The NADAC for ACETAMINOPHEN ER 650 MG CAPLET has been published 206 times since Oct 26, 2022, and over the history we have for it it has declined 10.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0631 per EA |
|---|---|
| All-time high | $0.0759 (Mar 15, 2023) |
| All-time low | $0.0610 (May 22, 2024) |
| 52-week high | $0.0686 |
| 52-week low | $0.0629 |
| Median price | $0.0686 |
| Average price | $0.0679 |
| Largest weekly change | +16.2% (Feb 22, 2023) |
| Weeks tracked | 206 |
| Tracking since | Oct 26, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ACETAMINOPHEN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Granules Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ACETAMINOPHEN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ACETAMINOPHEN ER 650 MG CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN ER 650 MG CAPLET, manufactured by Granules Pharmaceuticals Inc., is $0.0631 per EA (NDC 70010016001), effective Sep 30, 2026.
How has the price of ACETAMINOPHEN ER 650 MG CAPLET changed over time?
Over the history we have for it, the NADAC for ACETAMINOPHEN ER 650 MG CAPLET has declined 10.5%. It has been tracked across 206 weekly CMS publications since Oct 26, 2022.
What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN ER 650 MG CAPLET?
Since Oct 26, 2022, the NADAC for ACETAMINOPHEN ER 650 MG CAPLET has ranged from a low of $0.0610 (May 22, 2024) to a high of $0.0759 (Mar 15, 2023), with a median of $0.0686 per EA.
Are there cheaper alternatives to ACETAMINOPHEN ER 650 MG CAPLET?
No other NADAC-published product currently shares the active ingredient and strength of ACETAMINOPHEN ER 650 MG CAPLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ACETAMINOPHEN ER 650 MG CAPLET?
ACETAMINOPHEN ER 650 MG CAPLET (NDC 70010016001) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.